Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

LABA Label Changes Could Reinvigorate Single-Ingredient Products

Jun 07 2010

• By The Pink Sheet

Related Content

Respiratory Generics: Big Potential But A Tough Market To Crack

May 24 2010

LABA Safety Studies, REMS Are Next Topics For Sponsors, FDA After Relabeling

Jun 07 2010

Clinical Trials Or Observational Studies for Asthma? FDA Advisory Panels Can't Agree

Mar 12 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window